In vivo proton magnetic resonance spectroscopy of Alzheimer's disease in the parietal and temporal lobes

Biological Psychiatry

Volumn 42, Issue 2, 1997, Pages 147-150

  Frederick, Blaise DeB ^a,b   Satlin, Andrew ^a,b   Yurgelun Todd, Deborah A ^a,b   Renshaw, Perry F ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer's disease; N acetylaspartate; Parietal lobe; Proton magnetic resonance spectroscopy; Temporal lobe

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TEMPORAL LOBE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASPARTIC ACID; BRAIN MAPPING; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PARIETAL LOBE; REFERENCE VALUES; TEMPORAL LOBE;

EID: 0343144806     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00242-4     Document Type: Article

References (15)

1. Erkinjuntti T, Lee DH, Gao F, Steenhuis R, Eliasziw M, Fry R, et al (1993): Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease. Arch Neurol 50:305-310.
2. Holman BL, Johnson KA, Gerada B, Carvalho PA, Satlin A (1992): The scintigraphic appearance of Alzheimer's disease: A prospective study using technetium-99m-HMPAO SPECT. J Nucl Med 33:181-185.
3. Jagust WJ (1996): Functional imaging patterns in Alzheimer's disease. Relationships to neurobiology. Ann N Y Acad Sci 777:30-36.
4. Jobst KA, Smith AD, Szatmari M, Molyneux AJ, Esiri MM, King E, et al (1992): Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet 340:1179-1183.
5. Jobst KA, Smith AD, Szatmari M, Esiri MM, Jaskowski A, Hindley N, et al (1994): Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease. Lancet 343: 829-830.
6. Killiany RJ, Moss MB, Albert MS, Sandor T, Tieman J, Jolesz F (1993): Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol 50:949-954.
7. Klunk WE, Panchalingam K, Moossy J, McClure RJ, Pettegrew JW (1992): N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: A preliminary proton nuclear magnetic resonance study. Neurology 42:1578-1585.
8. Koller KJ, Zaczek R, Coyle JT (1984): N-acetyl-aspartyl-glutamate: Regional levels in rat brain and the effects of brain lesions as determined by new HPLC method. J Neurochem 43:1137-1142.
9. Kwo-On-Yuen PF, Newmark RD, Budinger TF, Kaye JA, Ball MJ, Jagust WJ (1994): Brain N-acetyl-L-aspartic acid in Alzheimer's disease: A proton magnetic resonance spectroscopy study. Brain Res 667:167-174.
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984): Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-944.
11. Meyerhoff DJ, MacKay S, Constans J-M, Norman D, Dyke CV, Fein G, et al (1994): Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 36:40-47.
12. Moats RA, Ernst T, Shonk TK, Ross BD (1994): Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med 32:110-115.
13. Mohanakrishnan P, Fowler AH, Vonsattel JP, Husain MM, Jolles PR, Liem P, et al (1995): An in vitro 1H nuclear magnetic resonance study of the temporoparietal cortex of Alzheimer brains. Exp Brain Res 102:503-510.
14. Shonk T, Moats R, Gifford P, Michaelis T, Mandigo JC, Izumi J, et al (1995): Probable Alzheimer disease: Diagnosis with proton MR spectroscopy. Radiology 195:65-72.
15. Simmons ML, Frondoza CG, Coyle JT (1991): Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45:37-45.